| Field | Specification |
|---|---|
| Alternative names | Vitamin B7 sodium; Vitamin H sodium; D-Biotin sodium |
| CAS no. | |
| Applications | |
| Source | Endogenous metabolite |
| Molecular weight | |
| Molecular formula | C10H15N2NaO3S |
| Activity | |
| SMILES | |
| Storage | |
| Shipping | |
| Catalog no. (Mfr.) | |
| Main SKU |
Compound Overview
Biotin sodium, also known as Vitamin B7 sodium, Vitamin H sodium, or D-Biotin sodium, is a water-soluble B vitamin that serves as a coenzyme for five carboxylases in humans, supporting the synthesis of fatty acids, isoleucine, and valine, as well as gluconeogenesis. It is necessary for cell growth and for the production of fatty acids and the metabolism of fats and amino acids[1][2][3]. It has the molecular formula C10H15N2NaO3S and a molecular weight of 266.29 g/mol.
Physical & Chemical Properties
| CAS Number | 56085-82-6 |
|---|---|
| Molecular Formula | C10H15N2NaO3S |
| Molecular Weight | 266.29 g/mol |
| Structure Classification | Others |
| SMILES | O=C(O[Na])CCCC[C@@H]1SC[C@]([C@]1([H])N2)([H])NC2=O |
| Signaling Pathway | Metabolic Enzyme/Protease |
| Bioactivity Class | Microbial Metabolite, Human Endogenous Metabolite |
| Initial Source | Endogenous metabolite |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Shipping | Room temperature in continental US; may vary elsewhere. |
Literature Cited
Sources cited in this description. Peer-reviewed publications that used this product are listed under References.
[1]. Zempleni, et al. Biotin biochemistry and human requirements. J Nutr Biochem, 1999. 10(3): p. 128-38.
[3]. Zempleni J, et al. Biotin. Biofactors. 2009 Jan-Feb;35(1):36-46.
Safety
For Research Use Only. Not for use in diagnostic or therapeutic procedures, and not for human or veterinary use. Handle in accordance with your institution's chemical hygiene plan.
Need this compound in a format that drops straight into your assay? We can tailor formulation, chemistry, and documentation so your results stay consistent across runs and re-orders.
- Format options: solid or pre-dissolved solution (choose solvent), target concentration, aliquots, light/moisture-protected packaging
- Chemistry options: free base/acid vs salt forms, hydrate/solvate preference, stereoisomer control (single enantiomer or racemate), close analogs
- Add-on labels & handles: D/¹³C/¹⁵N isotopes (LC-MS/internal standards), azide/alkyne or other functional handles for conjugation
- QC & documentation: standard COA or enhanced analytical pack (HPLC/LC-MS/NMR), chiral purity, residual solvents, water content (KF), method-specific specs
- Scale & continuity: mg to gram scale, bulk pricing, lot reservation, repeat-order continuity
To quote quickly, tell us: compound name + CAS/structure (SMILES or mol file), intended assay context, solvent preference, salt/stereochemistry requirements, purity/QC level, and the amount (mg–g).
Can’t find the compound you’re looking for?
Send the CAS or structure and your specs. We can help source it, suggest close equivalents, or discuss custom synthesis with the right QC documentation (RUO).
Regorafenib enhances anti-PDCD1/PD-1 therapeutic efficacy in colorectal cancer by promoting SQSTM1/p62-mediated CD274/PD-L1 degradation. Autophagy 2026 Jun;22(6):1203-1220. PMID: 41655134
Suppressing protein damage response to overcome multidrug resistance in cancer therapy. Cell Discov 2025 Sep 30;11(1):80. PMID: 41027888
CPT1A induction following epigenetic perturbation promotes MAVS palmitoylation and activation to potentiate antitumor immunity. Mol Cell 2023 Dec 7;83(23):4370-4385.e9. PMID: 38016475
Herb-sourced emodin inhibits angiogenesis of breast cancer by targeting VEGFA transcription. Theranostics 2020 May 22;10(15):6839-6853. PMID: 32550907
Obesity-driven oleoylcarnitine accumulation in tumor microenvironment promotes breast cancer metastasis-like phenotype. Acta Pharm Sin B 2025 Apr;15(4):1974-1990. PMID: 40486851
Dual CDK and MEK Inhibition potentiates CD8+ T cell-mediated antitumor immunity by inducing pyroptotic cell death in high-mutational head and neck cancer. J Exp Clin Cancer Res 2025 Nov 6;44(1):300. PMID: 41194215
Targeting ubiquitin-independent proteasome with small molecule increases susceptibility in pan-KRAS-mutant cancer models. J Clin Invest 2025 Mar 17;135(6):e185278. PMID: 40091835
Hepatocyte BDNF Acts as a Novel Immune Checkpoint to Restrain TLR4-Mediated Acute Hepatitis. Adv Sci (Weinh) 2026 Mar 25:e21164. PMID: 41881032
Caffeic acid, but not ferulic acid, inhibits macrophage pyroptosis by directly blocking gasdermin D activation. MedComm (2020) 2023 Apr 20;4(3):e255. PMID: 37090118
Sci Adv. 2025 Dec 19;11(51).
